GlassScriptPhysician profile
Robin Ravind Chand
NPI 1811253495
$15,763.21
in general payments reported to CMS, 2019-2025
33 companies · $3,011 in 2025
The $3,011 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,262 · 2020: $1,485 · 2021: $2,332 · 2022: $3,215 · 2023: $2,501 · 2024: $1,957 · 2025: $3,011.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,600 · Food and Beverage: $2,669 · Honoraria: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,600.00 |
| Food and Beverage | $2,668.64 |
| Honoraria | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $4,307.20 | 2021-2023 | Cardiosave Hybrid, Type B Plug |
| Pfizer INC. | $2,386.88 | 2019-2025 | |
| Biocryst Pharmaceuticals, INC. | $1,400.00 | 2020 | |
| Chiesi USA, INC. | $1,200.00 | 2024 | Juxtapid |
| Abbott Laboratories | $1,137.34 | 2019-2024 | Assurity, Tendril, Gallant |
| Astrazeneca Uk Limited | $1,000.00 | 2022 | |
| Medtronic Vascular, INC. | $840.73 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $511.77 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $382.79 | 2020-2025 | Lifevest |
| Aop Health US, LLC | $364.27 | 2025 | Rapiblyk |
| Abiomed | $247.78 | 2023-2024 | Impella |
| Heartflow, INC. | $243.37 | 2022-2025 | |
| Baxter Healthcare | $195.97 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Cardiac Ambulatory Monitor |
| Amgen INC. | $175.54 | 2019-2021 | |
| Impulse Dynamics (USA) INC. | $175.00 | 2023 | Optimizer |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $164.89 | 2022 | |
| Boston Scientific Corporation | $151.58 | 2019-2025 | S-Icd System Magnet |
| Regeneron Healthcare Solutions, INC. | $147.86 | 2024-2025 | Evkeeza, Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.79 | 2021-2023 | Jardiance |
| Janssen Pharmaceuticals, INC | $76.02 | 2023-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $63.93 | 2022-2024 | Andexxa |
| Scpharmaceuticals INC. | $62.71 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $60.36 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $58.44 | 2023-2024 | Inpefa |
| Merck Sharp & Dohme LLC | $53.25 | 2024-2025 | Winrevair, Verquvo |
| Cardiva Medical, INC. | $47.22 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $36.08 | 2023 | Camzyos |
| Csl Behring | $30.47 | 2025 | Kcentra |
| Datascope Corp. | $28.09 | 2021 | |
| Altathera Pharmaceuticals LLC | $27.60 | 2024 | Sotalol Hydrochloride |
| Philips North America LLC | $25.32 | 2025 | Disposable Vest |
| Astellas Pharma US INC | $23.68 | 2022 | |
| Medtronic, INC. | $20.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Chand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.